Gene · 3269
Papers3,179
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,179
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs. | Nat Commun | 2023 | 37468498 | PubTator, text mining | PubMed |
| GPCRome-wide analysis of G-protein-coupling diversity using a computational biology approach. | Nat Commun | 2023 | 37468476 | PubTator, text mining | PubMed |
| Histaminergic regulation of food intake. | Front Endocrinol (Lausanne) | 2023 | 37448468 | PubTator, text mining | PubMed |
| Fabrication and Applications of Potentiometric Membrane Sensors Based on γ-Cyclodextrin and Calixarene as Ionophores for the Determination of a Histamine H1-Receptor Antagonist: Fexofenadine. | Polymers (Basel) | 2023 | 37447454 | PubTator, text mining | PubMed |
| Association Between Opioid Use Disorder and Seizure Incidents Among Alcohol Use Disorder Patients. | Subst Abuse | 2023 | 37426877 | PubTator, text mining | PubMed |
| Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses. | J Immunother Cancer | 2023 | 37419511 | PubTator, text mining | PubMed |
| Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain. | J Med Chem | 2023 | 37418295 | PubTator, text mining | PubMed |
| Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput platform. | Nat Commun | 2023 | 37407564 | PubTator, text mining | PubMed |
| Cariprazine for Treating Schizophrenia, Mania, Bipolar Depression, and Unipolar Depression: A Review of Its Efficacy. | Cureus | 2023 | 37378203 | PubTator, text mining | PubMed |
| Emerging role of the gut microbiome in post-infectious irritable bowel syndrome: A literature review. | World J Gastroenterol | 2023 | 37377581 | PubTator, text mining | PubMed |
| Atopic Dermatitis: Disease Features, Therapeutic Options, and a Multidisciplinary Approach. | Life (Basel) | 2023 | 37374201 | PubTator, text mining | PubMed |
| Molecular Mechanism and Clinical Effects of Probiotics in the Management of Cow's Milk Protein Allergy. | Int J Mol Sci | 2023 | 37372929 | PubTator, text mining | PubMed |
| Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease. | Antioxidants (Basel) | 2023 | 37372013 | PubTator, text mining | PubMed |
| Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers. | Antioxidants (Basel) | 2023 | 37371940 | PubTator, text mining | PubMed |
| Using a Quantitative High-Throughput Screening Platform to Identify Molecular Targets and Compounds as Repurposing Candidates for Endometriosis. | Biomolecules | 2023 | 37371546 | PubTator, text mining | PubMed |
| Molecular Biophysics of Class A G Protein Coupled Receptors-Lipids Interactome at a Glance-Highlights from the A2A Adenosine Receptor. | Biomolecules | 2023 | 37371538 | PubTator, text mining | PubMed |
| Identification and validation of G protein-coupled receptors modulating flow-dependent signaling pathways in vascular endothelial cells. | Front Mol Biosci | 2023 | 37363403 | PubTator, text mining | PubMed |
| The pyridazine heterocycle in molecular recognition and drug discovery. | Med Chem Res | 2023 | 37362319 | PubTator, text mining | PubMed |
| Regulatory Perspective Reverse Engineering Analysis of the Mast Cell Stabilizer and the Histamine Receptor Antagonist (Olopatadine HCl): Instrumental and Classical Methods for Multiple Formulations. | ACS Omega | 2023 | 37360430 | PubTator, text mining | PubMed |
| Integrative single-cell multiomics analyses dissect molecular signatures of intratumoral heterogeneities and differentiation states of human gastric cancer. | Natl Sci Rev | 2023 | 37347037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3269/papers?page=13